Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02474160 · ClinicalTrials.gov registry record
Collection and Storage of Tissue and Blood Samples From Patients With Cancer
A clinical trial of Malignant Solid Neoplasm and Metastatic Malignant Solid Neoplasm, sponsored by National Cancer Institute LAO.
- Recruiting
- Registry status
- 5,000
- Enrollment target
- 20
- Study locations
NCT02474160: Recruiting study of Malignant Solid Neoplasm and Metastatic Malignant Solid Neoplasm, sponsored by National Cancer Institute LAO.
NCT02474160 is a study of Malignant Solid Neoplasm and Metastatic Malignant Solid Neoplasm that is actively recruiting participants, run by National Cancer Institute LAO. The registered enrollment target is 5,000 participants, above the 1,112-participant average among 176 other Malignant Solid Neoplasm trials with a reported enrollment target (350% higher). The trial reports 20 study locations across 8 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02474160, a study of Malignant Solid Neoplasm and Metastatic Malignant Solid Neoplasm, is actively recruiting participants, sponsored by National Cancer Institute LAO.
- RECRUITING
- Registry status
- 5,000 participants
- Enrollment target
- 20
- Study locations
Study Summary
This study collects and stores tissue and blood samples from patients with cancer. Collecting and storing samples of tissue and blood from patients with cancer to study in the laboratory may help scientists create new and better models to learn about cancer and to test new cancer drugs.
Primary Outcome
Tissues and venous blood will be stored, implanted immediately to generate patient-derived xenografts (which require fresh, viable cells), or placed immediately into in vitro cell culture to generate patient-derived cell lines (which require fresh, viable cells).
Conditions Studied
Interventions
- OTHER Cytology Specimen Collection Procedure
Study Locations (20)
Illinois
- OSF Saint Joseph Medical Center - Bloomington
- Illinois CancerCare-Bloomington - Bloomington
- Illinois CancerCare-Canton - Canton
- Memorial Hospital of Carbondale - Carbondale
- Illinois CancerCare-Carthage - Carthage
- Centralia Oncology Clinic - Centralia
Delaware
- Delaware Clinical and Laboratory Physicians PA - Newark
- Helen F Graham Cancer Center - Newark
- Medical Oncology Hematology Consultants PA - Newark
- Christiana Care Health System-Christiana Hospital - Newark
- Christiana Care Health System-Wilmington Hospital - Wilmington
California
- PCR Oncology - Arroyo Grande
- City of Hope Comprehensive Cancer Center - Duarte
- USC / Norris Comprehensive Cancer Center - Los Angeles
Connecticut
- Smilow Cancer Center/Yale-New Haven Hospital - New Haven
- Yale University - New Haven
Alabama
- University of Alabama at Birmingham Cancer Center - Birmingham
Arkansas
- Mercy Hospital Fort Smith - Fort Smith
Colorado
- UCHealth University of Colorado Hospital - Aurora
Georgia
- Augusta University Medical Center - Augusta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,000 participants |
| Start Date | 2015-05-19 |
| Est. Completion | 2026-05-04 |
What NCT02474160 shows while recruiting
NCT02474160 is an observational study that tracks outcomes without assigning an intervention. Its 5,000 participants enrollment target places it among the larger protocols in the corpus, above the 1,112-participant average among 176 other Malignant Solid Neoplasm trials with a reported enrollment target (350% higher).
The record links to 4 conditions, with Malignant Solid Neoplasm appearing as the primary indexed condition, and to 1 intervention - of which Cytology Specimen Collection Procedure is the first listed.
NCT02474160 names 20 study sites across 8 states, led by Illinois, Delaware, California.
Frequently Asked Questions
What is clinical trial NCT02474160 about?
NCT02474160 is a clinical study titled "Collection and Storage of Tissue and Blood Samples From Patients With Cancer". This study collects and stores tissue and blood samples from patients with cancer. Collecting and storing samples of tissue and blood from patients with cancer to study in the laboratory may help scientists create new and better models to learn about cancer and to test new cancer drugs.
What is the current status of trial NCT02474160?
This trial is currently recruiting. The enrollment target is 5,000 participants. The study started on 2015-05-19. Estimated completion is 2026-05-04.
What conditions does trial NCT02474160 study?
This clinical trial studies the following conditions: Malignant Solid Neoplasm, Metastatic Malignant Solid Neoplasm, Hematopoietic and Lymphatic System Neoplasm, Recurrent Malignant Solid Neoplasm.
What interventions are being tested in trial NCT02474160?
The interventions under investigation include: Cytology Specimen Collection Procedure (OTHER).
Who is sponsoring clinical trial NCT02474160?
This trial is sponsored by National Cancer Institute LAO, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02474160 being conducted?
This trial has 20 study locations across Alabama, Arkansas, California, Colorado, Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Malignant Solid Neoplasm
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02474160's enrollment target sits among peer trials
5,000 8th of 176 higher than 167 of 176 other Malignant Solid Neoplasm trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Malignant Solid Neoplasm trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Evaluation of Early Identification of Cognitive Side Effects of Immunotherapy
RECRUITING
-
Investigating Memory and Physical Activity After Cancer Treatment in Survivors of Adolescent and Young Adult Cancers
RECRUITING
-
Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable Cancer
RECRUITING · Phase 1
-
Exercise Program (TEAM Me) for the Improvement of Movement and Mobility in Pediatric and Adolescent and Young Adult Patients With Cancer Undergoing a Blood Stem Cell Transplant
RECRUITING · NA
-
Voices: Messages of Wisdom and Hope in the Face of Illness
RECRUITING
-
Genetic Testing for the Prevention of Cancer in Indigenous American Communities (JUNIPER Trial)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00060541 · 5,000 participants
Evaluation and Treatment of Neurosurgical Disorders
- NCT00575081 · 5,000 participants
Physiological Brain Atlas Development
- NCT00736749 · 5,000 participants
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
- NCT00900198 · 5,000 participants
Collection of Tissue Samples for Cancer Research
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI